Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
27.6M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
4.14M
-
Shares change
-
+37.7K
-
Total reported value, excl. options
-
$26.4M
-
Value change
-
+$241K
-
Number of buys
-
1
-
Number of sells
-
-2
-
Price
-
$6.38
Significant Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q4 2020
10 filings reported holding PHGE - BiomX Inc. - Common stock, par value $0.0001 per share as of Q4 2020.
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.14M shares
of 27.6M outstanding shares and own 15% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.31M shares), MMCAP International Inc. SPC (684K shares), RTW INVESTMENTS, LP (600K shares), MILLENNIUM MANAGEMENT LLC (460K shares), Taylor Wealth Management Partners (38.8K shares), LMR Partners LLP (29K shares), SILVERARC CAPITAL MANAGEMENT, LLC (13.8K shares), BlackRock Inc. (2.07K shares), UBS Group AG (0 shares), and J. Goldman & Co LP (150K shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.